Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Germany
/
Capital Goods
Create a narrative
thyssenkrupp nucera KGaA Community
XTRA:NCH2 Community
4
Narratives
written by author
1
Comments
on narratives written by author
85
Fair Values set
on narratives written by author
Community Investing Ideas
thyssenkrupp nucera KGaA
Popular
Undervalued
Overvalued
thyssenkrupp nucera KGaA
CH
Chris1
Community Contributor
Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth
EBIT-margin trajectory: Historical: 2.3 % → 3.6 % (FY 22/23) , down to – 2 % (FY 23/24) , back to 3 % in Q1 24/25 Forecast: Gradual recovery to 4–6 % by FY 25/26, reaching 6–8 % by FY 29/30 Revenue growth: Historical: + 70 % (FY 22/23) , + 30 % (FY 23/24) , + 27 % (Q1 24/25) Forecast: ~ 15 % CAGR over the next five years (FY 24/25–29/30) Five-year share-price goal: Current fair value: € 8.5–9.0 per share Five-year target: € 14–15 per share (≈ 1.9 bn EUR market cap) Enterprise value (EV) outlook (DCF-based): Revenues rising to ~ 1.8 bn EUR by FY 29/30 EBIT of ~ 145 m EUR (8 % margin) → NOPAT ~ 102 m EUR FCF margin ~ 5 % → ~ 90 m EUR FCF Terminal-value multiple: EV/FCF = 15 → TV ~ 1.35 bn EUR Discounted EV: ≈ 1.18 bn EUR + net cash 0.69 bn EUR → ≈ 1.87 bn EUR → ~ 14.8 EUR/share Top risks: execution delays, margin pressure from competition, raw-material cost swings, subsidy uncertainty, heavy capex needs Narrative Outlook Over the next five years, thyssenkrupp nucera is poised to leverage its unique position at the intersection of mature Chlor-Alkali expertise and rapid Green-Hydrogen adoption. After a transitional phase in FY 23/24 with negative margins driven by upfront investments, the company’s shift toward series-manufactured AWE modules and high-growth project backlog supports a steady margin recovery.
View narrative
€14.40
FV
36.9% undervalued
intrinsic discount
15.00%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
1
users have commented on this narrative
21
users have followed this narrative
4 months ago
author updated this narrative
thyssenkrupp nucera KGaA
AN
AnalystHighTarget
Consensus Narrative from 10 Analysts
NEOM And Shell Rotterdam Will Spur Global Hydrogen Expansion
Key Takeaways Rapid conversion of key contracts, robust project execution, and recurring service revenues are set to accelerate high-margin growth and expand segment profitability. Advanced technology acquisitions, strong partnerships, and an asset-light model enable industry leadership in green hydrogen and resilience for long-term market expansion.
View narrative
€16.74
FV
45.7% undervalued
intrinsic discount
15.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
about 23 hours ago
author updated this narrative
thyssenkrupp nucera KGaA
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
US Policy Shifts And Project Cancellations Will Hamper Green Hydrogen
Key Takeaways Delays, cancellations, and shifting project scales in green hydrogen are expected to constrain revenue growth and increase volatility in sales performance. Rising protectionism, project concentration, and fierce global competition threaten export growth, margins, and long-term pricing power.
View narrative
€8.70
FV
4.4% overvalued
intrinsic discount
-10.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 9 hours ago
author updated this narrative
thyssenkrupp nucera KGaA
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Global Decarbonization Policies Will Fuel Green Hydrogen Momentum
Key Takeaways Positioned to benefit from rising global green hydrogen demand, with policy support and growing engineering contracts pointing to strengthened long-term growth and order visibility. Service expansion, strategic acquisitions, and advanced R&D support higher-margin revenues, improved earnings quality, and greater competitiveness in core and emerging markets.
View narrative
€12.00
FV
24.3% undervalued
intrinsic discount
-2.38%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
NCH2
NCH2
thyssenkrupp nucera KGaA
Your Fair Value
€
Current Price
€9.09
30.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
931m
2015
2018
2021
2024
2025
2027
2030
Revenue €930.8m
Earnings €16.4m
Advanced
Set Fair Value